Compound Detail
CHEMBL3945421
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(CN4CCN(CCC(=O)NO)CC4)cc3)cc12)c1ccccc1
Basic Information
| ChEMBL ID | CHEMBL3945421 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YDAWJAAODJNQFL-HXUWFJFHSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
499.6
MW (Da)
3.81
ALogP
7
HBA
4
HBD
109.4
PSA (Ų)
0.20
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | IC50 | = | 100.0 | nM | 7.0 | Inhibition of N-terminal GST-His6-thrombin cleavage site-fused human VEGFR2 (Asp... | - |
Data from ChEMBL 36 via Core Engine